These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7747920)

  • 61. Hybrid bioartificial kidney: pitfalls and present state of the art.
    Vanholder R
    Contrib Nephrol; 1993; 103():160-7. PubMed ID: 8354058
    [No Abstract]   [Full Text] [Related]  

  • 62. Biocompatibility issues of implantable drug delivery systems.
    Park H; Park K
    Pharm Res; 1996 Dec; 13(12):1770-6. PubMed ID: 8987070
    [No Abstract]   [Full Text] [Related]  

  • 63. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects.
    Scharp DW; Swanson CJ; Olack BJ; Latta PP; Hegre OD; Doherty EJ; Gentile FT; Flavin KS; Ansara MF; Lacy PE
    Diabetes; 1994 Sep; 43(9):1167-70. PubMed ID: 8070618
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bioartificial pancreas. Present state and future prospects.
    Reach G
    Biomed Biochim Acta; 1984; 43(5):569-76. PubMed ID: 6433904
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Self-regulated closed-loop therapy of diabetes].
    Reach G
    Ann Endocrinol (Paris); 1995; 56(1):43-8. PubMed ID: 7747920
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Artificial and bioartificial pancreas for the treatment of diabetes mellitus].
    Reach G
    Diabete Metab; 1994; 20(2 Pt 2):183-93. PubMed ID: 8001705
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bioartificial pancreas.
    Reach G
    Transplant Proc; 1994 Apr; 26(2):397-8. PubMed ID: 8171475
    [No Abstract]   [Full Text] [Related]  

  • 68. Novel delivery of pancreatic islet cells to treat insulin-dependent diabetes mellitus.
    Maki T; Mullon CJ; Solomon BA; Monaco AP
    Clin Pharmacokinet; 1995 Jun; 28(6):471-82. PubMed ID: 7656505
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biocompatibility and immunology in the encapsulation of islets of Langerhans (bioartificial pancreas).
    Zekorn TD; Horcher A; Mellert J; Siebers U; Altug T; Emre A; Hahn HJ; Federlin K
    Int J Artif Organs; 1996 Apr; 19(4):251-7. PubMed ID: 8786177
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An overview on the development of a bio-artificial pancreas as a treatment of insulin-dependent diabetes mellitus.
    Silva AI; de Matos AN; Brons IG; Mateus M
    Med Res Rev; 2006 Mar; 26(2):181-222. PubMed ID: 16342061
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The bioartificial pancreas: progress and challenges.
    Kizilel S; Garfinkel M; Opara E
    Diabetes Technol Ther; 2005 Dec; 7(6):968-85. PubMed ID: 16386103
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.